InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（8 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
8
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the detailed record of transactions filed by Namouni Fouad, Président et Directeur de la Recherche et Développement. Insider active across 2 companies, notably Aprea Therapeutics, Inc.. In total, 14 filings have been published. Breakdown: 0 buy · 8 sells. Total volume traded: €2m. History available since 30 June 2021. The latest transaction was disclosed on 5 March 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Namouni Fouad
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报14 总计
39,456 股Common StockSEC:0001104659-25-069383:0
6,489 股@ US$88.8023.7% 占其流量Common StockSEC:0001415889-25-007402:0
13,200 股0Common StockSEC:0001415889-25-006602:0
3,633 股@ US$89.3212.8% 占其流量Common StockSEC:0001415889-24-024776:0
4,377 股@ US$90.6915.9% 占其流量Common StockSEC:0001415889-24-007554:0
15,000 股0Common StockSEC:0001415889-24-007021:0
3,769 股@ US$48.067.5% 占其流量Common StockSEC:0001415889-23-014022:0
1,885 股@ US$45.723.5% 占其流量Common StockSEC:0001415889-23-004564:0
15,000 股0Common StockSEC:0001415889-23-004262:0
3,477 股@ US$67.3010.2% 占其流量Common StockSEC:0001415889-22-010366:0
1,047 股@ US$56.192.7% 占其流量Common StockSEC:0001415889-22-002738:0
15,000 股0Common StockSEC:0001415889-22-002432:0
3,241 股@ US$98.1813.6% 占其流量Common StockSEC:0001179110-21-009297:0
4,610 股0Common StockSEC:0001567619-21-012871:0
14 条申报中的 14 条
About Namouni Fouad
Namouni Fouad is President and Head of Research and Development. He is associated with Blueprint Medicines Corp and Aprea Therapeutics, Inc., and his 14 filings, based on the recent sample of 14 filings, cover disposals between 2021-07-01 and 2025-07-21 for a total of EUR 2016838.
